Further studies will be required to identify CPT1b-specific inhibitors, and to confirm the effectiveness and safety of prolonged inhibition of CPT1b in animals and in patients with insulin resistance and type II diabetes. The gene discussed is CPT1B; the disease is type 2 diabetes mellitus.